Article Versions Notes

Li D, Hemati H, Park Y, Taftaf R, Zhang Y, Liu J, Cristofanilli M, Liu X. ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer. Cancers. 2023; 15(10):2734. https://doi.org/10.3390/cancers15102734

Li, Dong, Hami Hemati, Younhee Park, Rokana Taftaf, Youbin Zhang, Jinpeng Liu, Massimo Cristofanilli, and Xia Liu. 2023. "ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer" Cancers 15, no. 10: 2734. https://doi.org/10.3390/cancers15102734

Li, D., Hemati, H., Park, Y., Taftaf, R., Zhang, Y., Liu, J., Cristofanilli, M., & Liu, X. (2023). ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer. Cancers, 15(10), 2734. https://doi.org/10.3390/cancers15102734